-
Recent Posts
Recent Comments
Archives
- October 2012
- December 2011
- November 2011
- September 2011
- March 2011
- December 2010
- November 2010
- September 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- November 2009
- October 2009
- September 2009
- July 2009
- June 2009
- February 2009
- January 2009
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- May 2008
- April 2008
- March 2008
- February 2008
- January 2008
- December 2007
- November 2007
- October 2007
- September 2007
- August 2007
- July 2007
- June 2007
- May 2007
- February 2007
- December 2006
- November 2006
- October 2006
- August 2006
- April 2006
- March 2006
- December 2005
- November 2005
- July 2005
- March 2005
- February 2005
- January 2005
- December 2004
- November 2004
- October 2004
- September 2004
- August 2004
Categories
Meta
Category Archives: Uncategorized
Recent publications
Papers Cox AR, Kirkham H. A Case Study of a Graphical Misrepresentation: Drawing the Wrong Conclusions about the Measles, Mumps and Rubella Virus Vaccine. Drug Safety 2007; 30(10): 831-836. Conference presentations Cox AR, Anton C, Marriott JF, Ferner RE. The … Continue reading
Posted in Uncategorized
Comments Off
Prescription charge refund for rofecoxib (Vioxx)
Patients who were taking the now withdrawn drug rofecoxib will be able to claim their last prescription charge back from the company – MSD.
Posted in Uncategorized
Comments Off
International Society of Pharmacovigilance annual meeting 2004
The Centre presented its reseach into encouraging reporters by enhancing feedback at the recent ISOP meeting in Dublin. The PowerPoint presentation may be viewed here. Christopher Anton presents the results of the GP invention study in Dublin.
Posted in Uncategorized
Comments Off
Canadian ADR bulletin published
Health Canada have published their latest Adverse Reaction Newsletter covering fentanyl and respiratory arrest in adolescents, infliximab and etanercept and serious respiratory infections, bitter orange (synephrine) and cardiovascular reactions
Posted in Uncategorized
Comments Off
MHRA advice about Vioxx
MHRA message to healthcare professionals. Press Statement. Questions and Answers.
Posted in Uncategorized
Comments Off
Vioxx (rofecoxib) withdrawn
“The Food and Drug Administration (FDA) today acknowledged the voluntary withdrawal from the market of Vioxx (chemical name rofecoxib), a non-steroidal anti-inflammatory drug (NSAID) manufactured by Merck & Co. FDA today also issued a Public Health Advisory to inform patients … Continue reading
Posted in Uncategorized
Comments Off
Interaction between lamotrigine and hormonal contraceptives
GlaxoSmithKline and Health Canada have issued a warning about an interaction between lamotrigine (Lamictal) and female hormonal contraceptives. A study has shown significant reductions in the blood concentration of lamotrigine in women taken both. There were also reports of break-through … Continue reading
Posted in Uncategorized
Comments Off
Australian ADR bulletin published
ADRAC have published their latest bulletin featuring: ADRs to pneumococcal vaccine, risk of suicide with high dose tricyclic antidepressants, terbinafine and blood dyscrasias, cholinesterase inhibitors and cardiac arrhythmias, and quinine and thrombocytopenia. http://www.tga.gov.au/adr/aadrb/aadr0410.pdf
Posted in Uncategorized
Comments Off
Our latest bulletin is published
re:Action 30 has just been published with articles on ADRs causing hospital admission, combination antiretrovirals and pancreatitis, photosensitivity reactions and a possible interaction between statins and thiazolidinediones.
Posted in Uncategorized
Comments Off
Anti-depressants in teenagers
“Top officials of the Food and Drug Administration have acknowledged for the first time that antidepressants appeared to lead some children and teenagers to become suicidal. Dr. Robert Temple, director of the food agency’s office of medical policy, said after … Continue reading
Posted in Uncategorized
Comments Off